Wymax Pharma And Research Private Limited - Company Profile

It is a chemicals private limited company based in Parwanoo, Himachal Pradesh, India, established in 2021.
2021 Parwanoo, Himachal Pradesh, India Active
Last Updated:
Access Report
About Wymax Pharma And Research Private Limited

Wymax Pharma And Research Private Limited, a active private limited company, was established on 29 July 2021 in Parwanoo, Himachal Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24231HP2021PTC008716. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Kshetrimayum Chitrarekha Devi (Director), Ningombam Robita Devi (Director), Elangbam Monorama Devi (Director). It is based at Sanjay Aluminium Private Limited, 41 Sec-2, Parwanoo, Himachal Pradesh, 173220.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231HP2021PTC008716

  • Registration Number

    008716

  • Incorporation Date

    29 July 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 6 Months
Company report

Wymax Pharma And Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Wymax Pharma And Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Wymax Pharma And Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Kshetrimayum Chitrarekha Devi Director 29 Jul 2021 Current
Ningombam Robita Devi Director 29 Jul 2021 Current
Elangbam Monorama Devi Director 29 Jul 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wymax Pharma And Research.

Enhance accessibility to Wymax Pharma And Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Wymax Pharma And Research revenue growth over time
Wymax Pharma And Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wymax Pharma And Research?

Unlock access to Wymax Pharma And Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Wymax Pharma And Research?

Unlock and access historical data on people associated with Wymax Pharma And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wymax Pharma And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wymax Pharma And Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wymax Pharma And Research
Recent Activity within the Organization
  • Director Appointment

    Kshetrimayum Chitrarekha Devi was appointed as a Director was appointed as a Director on 29 Jul 2021 & has been associated with this company since 4 years 6 months . was recorded as a recent event.

  • Director Appointment

    The activity Ningombam Robita Devi was appointed as a Director was appointed as a Director on 29 Jul 2021 & has been associated with this company since 4 years 6 months . was completed.

  • Director Appointment

    The activity Elangbam Monorama Devi was appointed as a Director was appointed as a Director on 29 Jul 2021 & has been associated with this company since 4 years 6 months . was completed.

  • Company Incorporation

    Wymax Pharma And Research Private Limited was registered on 29 Jul 2021 with Roc Himachal Pradesh & aged 4 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wymax Pharma And Research Private Limited?

The CIN of Wymax Pharma And Research Private Limited is U24231HP2021PTC008716.

Where is Wymax Pharma And Research Private Limited headquartered?

Wymax Pharma And Research Private Limited is headquartered at Sanjay Aluminium Private Limited, 41 Sec-2, Parwanoo, Himachal Pradesh, 173220.

When was Wymax Pharma And Research Private Limited incorporated?

Wymax Pharma And Research Private Limited was incorporated on 29 July 2021.

Who are the current directors of Wymax Pharma And Research Private Limited?

The current directors of Wymax Pharma And Research Private Limited are

What is the primary industry of Wymax Pharma And Research Private Limited?

The primary industry of Wymax Pharma And Research Private Limited is Chemicals.

Is Wymax Pharma And Research Private Limited a listed company?

Wymax Pharma And Research Private Limited is unlisted.

What is the capital structure of Wymax Pharma And Research Private Limited?

The authorized capital of Wymax Pharma And Research Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available